Earnings ·
NeuroOne reports $10.5M FY revenue, secures record $4.5M purchase order
NMTCNEUROONE MEDICAL TECHNOLOGIES Corp
NeuroOne Medical Technologies reported preliminary fiscal 2026 product revenue of approximately $10.5 million, representing 15.6% year-over-year growth and landing at the top of its guidance range. Fourth-quarter revenue was approximately $3.8 million, up 38.4% from the prior year period. The company also announced it secured a record $4.5 million purchase order in September 2026, with $1.0 million shipped by quarter-end and the remaining $3.6 million expected to ship in fiscal 2027. Total open orders reached $5.4 million as of September 30, 2026. NeuroOne Medical Technologies Corporation is a medical technology company focused on surgical diagnosis and treatment of neurological disorders.